Key Metrics
CiteScore 

31
Scite Index 

0.86 5-Year SI

SNIP 

6.95
Recommended pre-submission checks
Powered by 

The Lancet Gastroenterology and Hepatology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ELSEVIER INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet Gastroenterology and Hepatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in The Lancet Gastroenterology and Hepatology
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Upfront medical or surgical treatment in Crohn's disease.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Wee, Poo, Snot: harnessing bodily functions to inspire budding scientists.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Upfront medical or surgical treatment in Crohn's disease.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology
Wee, Poo, Snot: harnessing bodily functions to inspire budding scientists.
- 1 Jul 2026
- The lancet. Gastroenterology & hepatology